{"hands_on_practices": [{"introduction": "The semen analysis is a cornerstone of the male infertility evaluation. Rather than assessing individual parameters in isolation, clinicians often synthesize volume, concentration, and motility into a single, functional metric: the Total Motile Sperm Count (TMSC). This exercise [@problem_id:4435622] will guide you through deriving the TMSC from first principles, providing a fundamental quantitative skill that directly informs clinical decisions, such as determining a couple's suitability for intrauterine insemination (IUI).", "problem": "A couple is undergoing evaluation for infertility. A semen analysis is performed after appropriate abstinence and standard liquefaction. The laboratory reports the following pre-wash parameters: semen volume $V = 2.0$ mL, sperm concentration $C = 20 \\times 10^{6}$ per mL, and progressive motility $m = 40\\%$ (equivalently, $m = 0.40$ as a fraction). Using only the fundamental definitions that (i) concentration is the number of entities per unit volume and (ii) a proportion $m$ denotes the fraction of a total that has the specified property, derive from first principles an expression for the Total Motile Sperm Count (TMSC), defined as the number of sperm in the ejaculate that are progressively motile, and compute its value for this sample. Round your numerical result to two significant figures and express the final TMSC in millions (that is, as a count in units of $\\times 10^{6}$ sperm). Then, based on the common clinical heuristic that proceeding with intrauterine insemination (IUI) is generally acceptable when the pre-wash TMSC is at least $10 \\times 10^{6}$, justify whether these data meet that heuristic. Only report the requested TMSC value in millions; do not include the interpretation in your final numeric answer.", "solution": "The problem statement is subjected to validation.\n\n**Step 1: Extract Givens**\n- Semen volume: $V = 2.0$ mL\n- Sperm concentration: $C = 20 \\times 10^{6}$ per mL\n- Progressive motility: $m = 40\\%$ ($m = 0.40$)\n- Definition (i): Concentration is the number of entities per unit volume.\n- Definition (ii): A proportion $m$ denotes the fraction of a total that has the specified property.\n- Definition of TMSC: The number of sperm in the ejaculate that are progressively motile.\n- Clinical heuristic: Intrauterine insemination (IUI) is acceptable if pre-wash Total Motile Sperm Count (TMSC) is at least $10 \\times 10^{6}$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, well-posed, and objective. It provides a set of standard, realistic clinical parameters from the field of andrology and reproductive medicine. The definitions provided for concentration and proportion are fundamental and mathematically sound. The problem is self-contained, with all necessary data and definitions provided to derive a unique and meaningful solution. There are no contradictions, ambiguities, or scientifically unsound premises.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A complete solution will be provided.\n\n**Derivation and Calculation**\n\nThe problem requires the derivation of an expression for the Total Motile Sperm Count (TMSC) from first principles.\n\nLet $N_{total}$ be the total number of sperm in the ejaculate. Let $V$ be the volume of the ejaculate, and let $C$ be the sperm concentration. According to the provided definition (i), concentration is the number of entities per unit volume. Mathematically, this is expressed as:\n$$C = \\frac{N_{total}}{V}$$\nFrom this fundamental relationship, we can express the total number of sperm, $N_{total}$, by rearranging the equation:\n$$N_{total} = C \\times V$$\n\nNext, let $N_{motile}$ represent the number of sperm in the ejaculate that are progressively motile. This quantity is, by definition, the TMSC. So, $\\text{TMSC} = N_{motile}$. The problem provides the progressive motility, $m$, as the fraction of the total sperm that possesses this property, as per definition (ii). This can be written as:\n$$m = \\frac{N_{motile}}{N_{total}}$$\nBy rearranging this equation, we can express the number of motile sperm as:\n$$N_{motile} = m \\times N_{total}$$\n\nTo obtain a single expression for the TMSC in terms of the initial given parameters ($V$, $C$, and $m$), we substitute the expression for $N_{total}$ into the equation for $N_{motile}$:\n$$N_{motile} = m \\times (C \\times V)$$\nThus, the derived expression for the Total Motile Sperm Count is:\n$$\\text{TMSC} = V \\times C \\times m$$\n\nNow, we compute the value of the TMSC for the given sample using the provided data:\n- Semen volume: $V = 2.0 \\text{ mL}$\n- Sperm concentration: $C = 20 \\times 10^{6} \\text{ mL}^{-1}$\n- Progressive motility (as a fraction): $m = 0.40$\n\nSubstituting these values into the derived formula:\n$$\\text{TMSC} = (2.0 \\text{ mL}) \\times (20 \\times 10^{6} \\text{ mL}^{-1}) \\times 0.40$$\nThe units of volume (mL and $\\text{mL}^{-1}$) cancel, yielding a dimensionless count, as expected for a number of entities.\n$$\\text{TMSC} = (40 \\times 10^{6}) \\times 0.40$$\n$$\\text{TMSC} = 16 \\times 10^{6}$$\nThe total motile sperm count is $16 \\times 10^{6}$. The problem requires this value to be expressed in millions (i.e., as a number multiplied by $10^{6}$) and rounded to two significant figures. The calculated value $16$ already has two significant figures, so no rounding is necessary. The value is $16$ million.\n\nFinally, the problem asks for a justification regarding the clinical heuristic for proceeding with IUI. The heuristic suggests that an IUI is acceptable if the pre-wash TMSC is at least $10 \\times 10^{6}$.\nOur calculated TMSC is $16 \\times 10^{6}$.\nComparing the calculated value to the threshold:\n$$16 \\times 10^{6} > 10 \\times 10^{6}$$\nSince the calculated TMSC of $16 \\times 10^{6}$ is greater than the minimum threshold of $10 \\times 10^{6}$, these data meet the common clinical heuristic for proceeding with IUI.", "answer": "$$\n\\boxed{16}\n$$", "id": "4435622"}, {"introduction": "Successful conception, whether natural or assisted, critically depends on the accurate identification of the female partner's fertile window. This clinical scenario [@problem_id:4435542] challenges you to act as a reproductive specialist, synthesizing multiple streams of dynamic data—serial ultrasound follicle measurements, serum estradiol levels, and urinary LH tests—to precisely pinpoint the timing of ovulation. Mastering this interpretive skill is essential for counseling patients and planning interventions like timed intercourse or IUI.", "problem": "A 32-year-old nulligravida with regular 28-day cycles is undergoing natural-cycle monitoring for timed conception. Serial transvaginal ultrasonography (TVUS) and serum estradiol are obtained, and she is using home urinary luteinizing hormone (LH) testing. You are asked to identify the most likely day of ovulation and to plan the timing for intercourse or a natural-cycle intrauterine insemination (IUI). The cycle data are as follows:\n\nCycle day 9: Right ovarian dominant follicle measures 12 mm; serum estradiol 130 pg/mL; urinary LH negative.\n\nCycle day 11: Follicle 16 mm; estradiol 230 pg/mL; urinary LH negative.\n\nCycle day 12: Follicle 18 mm; estradiol 300 pg/mL; urinary LH negative.\n\nCycle day 13 morning: Follicle 20 mm; estradiol 420 pg/mL; urinary LH negative.\n\nCycle day 14 morning: Follicle 21 mm; estradiol 500 pg/mL; urinary LH strongly positive.\n\nCycle day 15 morning: TVUS shows follicle collapse with an irregular residual follicular structure measuring 12 mm and moderate free fluid in the cul-de-sac; estradiol 160 pg/mL.\n\nBased on fundamental reproductive physiology, which option best identifies the most likely day of ovulation and provides an appropriate timing plan for intercourse or a natural-cycle IUI keyed to the spontaneous LH surge?\n\nA. Ovulation most likely occurred between late cycle day 14 and early cycle day 15; recommend intercourse on cycle day 13 evening and cycle day 14, and schedule the natural-cycle IUI approximately 24 hours after the first positive LH (cycle day 15 morning).\n\nB. Ovulation most likely occurred on cycle day 14 morning; recommend IUI 6 hours after the first positive LH and intercourse only on cycle day 14 evening.\n\nC. Ovulation most likely occurred on cycle day 16; because the follicle had not yet reached 22–24 mm, trigger with human chorionic gonadotropin (hCG) on cycle day 15 and perform IUI 36 hours later on cycle day 17 morning.\n\nD. Ovulation most likely occurred on cycle day 13; recommend intercourse only on cycle day 13 morning, and if doing IUI, perform it on cycle day 13 afternoon.", "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Patient Profile**: A 32-year-old nulligravida with regular 28-day cycles.\n- **Monitoring Protocol**: Natural-cycle monitoring for timed conception using serial transvaginal ultrasonography (TVUS), serum estradiol measurements, and home urinary luteinizing hormone (LH) testing.\n- **Cycle Data**:\n    - **Cycle day 9**: Right ovarian dominant follicle measures 12 mm; serum estradiol 130 pg/mL; urinary LH negative.\n    - **Cycle day 11**: Follicle 16 mm; estradiol 230 pg/mL; urinary LH negative.\n    - **Cycle day 12**: Follicle 18 mm; estradiol 300 pg/mL; urinary LH negative.\n    - **Cycle day 13 morning**: Follicle 20 mm; estradiol 420 pg/mL; urinary LH negative.\n    - **Cycle day 14 morning**: Follicle 21 mm; estradiol 500 pg/mL; urinary LH strongly positive.\n    - **Cycle day 15 morning**: TVUS shows follicle collapse with an irregular residual follicular structure measuring 12 mm and moderate free fluid in the cul-de-sac; estradiol 160 pg/mL.\n- **Question**: Identify the most likely day of ovulation and the appropriate timing for intercourse or natural-cycle intrauterine insemination (IUI) keyed to the spontaneous LH surge.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem is based on the fundamental principles of reproductive endocrinology and the physiology of the human menstrual cycle.\n    - **Follicular Growth**: The dominant follicle grows from 12 mm on day 9 to 21 mm on day 14. The average growth rate is (21 - 12) mm / (14 - 9) days = 9 mm / 5 days = 1.8 mm/day. This is consistent with the expected follicular growth rate of 1–2 mm/day in the mid-to-late follicular phase.\n    - **Estradiol Dynamics**: Serum estradiol rises steadily, correlating with follicular growth, from 130 pg/mL to a pre-ovulatory peak of 500 pg/mL. This level, while high for a single follicle, is physiologically plausible and effectively triggers the LH surge. The subsequent sharp drop to 160 pg/mL is characteristic of the period immediately following ovulation.\n    - **LH Surge and Ovulation**: A spontaneous LH surge is detected on cycle day 14 morning when the follicle is mature (21 mm) and estradiol is at its peak. Ovulation is known to occur approximately 24–36 hours after the onset of the LH surge.\n    - **Sonographic Evidence of Ovulation**: The findings on cycle day 15 morning—follicular collapse, presence of free fluid, and an irregular residual structure—are definitive signs that ovulation has already occurred.\n    The data provided are internally consistent and accurately reflect a normal ovulatory cycle.\n2.  **Well-Posed**: The problem provides a complete set of clinical data sufficient to deduce the timing of ovulation and to evaluate the appropriateness of different conception strategies. A unique, stable, and meaningful solution exists.\n3.  **Objective**: The problem uses precise, objective clinical terminology and quantitative data. It is free of subjective or ambiguous language.\n\n### Step 3: Verdict and Action\nThe problem is **valid** as it is scientifically sound, well-posed, objective, and internally consistent. A solution will now be derived.\n\n### Derivation of Solution\nThe solution requires a two-part analysis: first, determining the most likely time of ovulation from the provided data, and second, establishing the optimal timing for intercourse and IUI based on this determination.\n\n**1. Identification of the Ovulation Window**\n\n- The LH surge is the primary endocrine trigger for ovulation. In this case, the urinary LH test was first positive on the morning of cycle day 14. This indicates the LH surge is in progress.\n- Ovulation typically occurs 24 to 36 hours after the *onset* of the endogenous LH surge, or approximately 10 to 12 hours after the LH *peak*. The positive urinary test confirms the surge has reached a detectable threshold.\n- The TVUS on the morning of cycle day 15 showed unequivocal evidence of a completed ovulation (follicle collapse, free fluid). This means ovulation occurred sometime in the 24-hour interval between the monitoring visit on the morning of day 14 (when the follicle was intact) and the visit on the morning of day 15.\n- Combining these facts, the LH surge was detected on the morning of day 14. Ovulation must have followed this event and preceded the morning of day 15. Therefore, the most probable time for ovulation is the period between the late afternoon/evening of cycle day 14 and the early morning of cycle day 15.\n\n**2. Optimal Timing for Conception**\n\n- **Timed Intercourse**: The goal is to ensure sperm are present in the fallopian tube at the time of ovulation. Sperm are viable in the female reproductive tract for up to 5 days, whereas the oocyte is viable for only about 12–24 hours post-ovulation. The most fertile window comprises the few days leading up to and including the day of ovulation. Given that ovulation is expected on late day 14 or early day 15, recommending intercourse on the evening of cycle day 13 and on cycle day 14 brackets the time of ovulation optimally. This maximizes the probability of viable sperm being present when the oocyte is released.\n\n- **Natural-Cycle IUI**: IUI places a concentrated population of motile sperm directly into the uterus, reducing the transit time to the fallopian tube. The timing of IUI is therefore more critical and should be synchronized as closely as possible with ovulation. Standard clinical practice for a single IUI in a natural cycle is to perform the procedure 24 to 36 hours after the detection of the LH surge. The LH surge was detected on the morning of cycle day 14. Performing the IUI on the morning of cycle day 15 would place it approximately 24 hours after the detected surge, which is an ideal time to coincide with the predicted ovulation window.\n\n### Option-by-Option Analysis\n\n**A. Ovulation most likely occurred between late cycle day 14 and early cycle day 15; recommend intercourse on cycle day 13 evening and cycle day 14, and schedule the natural-cycle IUI approximately 24 hours after the first positive LH (cycle day 15 morning).**\n- **Ovulation Timing**: This accurately reflects the physiological interpretation of the data, as derived above. **Correct**.\n- **Intercourse Plan**: This recommendation effectively covers the fertile window. **Correct**.\n- **IUI Plan**: This timing is consistent with established clinical protocols for IUI. **Correct**.\nThe entire statement is physiologically and clinically sound.\n**Verdict: Correct**\n\n**B. Ovulation most likely occurred on cycle day 14 morning; recommend IUI 6 hours after the first positive LH and intercourse only on cycle day 14 evening.**\n- **Ovulation Timing**: This is incorrect. On the morning of cycle day 14, the follicle was still intact (21 mm) on TVUS, and the LH surge had just been detected. Ovulation follows the surge, it does not coincide with its initial detection.\n**Verdict: Incorrect**\n\n**C. Ovulation most likely occurred on cycle day 16; because the follicle had not yet reached 22–24 mm, trigger with human chorionic gonadotropin (hCG) on cycle day 15 and perform IUI 36 hours later on cycle day 17 morning.**\n- **Ovulation Timing and Intervention**: This is factually incorrect. The TVUS on day 15 morning provided definitive evidence that ovulation had *already occurred*. Therefore, ovulation on day 16 is impossible, and triggering with hCG on day 15 is illogical. Furthermore, while many follicles ovulate at 22–24 mm, the 21 mm follicle was clearly mature enough to ovulate, as evidenced by the spontaneous LH surge and subsequent ovulation.\n**Verdict: Incorrect**\n\n**D. Ovulation most likely occurred on cycle day 13; recommend intercourse only on cycle day 13 morning, and if doing IUI, perform it on cycle day 13 afternoon.**\n- **Ovulation Timing**: This is incorrect. On cycle day 13, the urinary LH was negative. Ovulation does not precede the LH surge. The follicle was still growing and had not yet received the signal to rupture.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "4435542"}, {"introduction": "Modern medical practice demands that we interpret diagnostic tests not as simple \"positive\" or \"negative\" results, but within the context of a patient's prior risk. This advanced exercise [@problem_id:4435621] introduces a powerful quantitative tool, Bayes' theorem, to formally update a patient's age-based probability of diminished ovarian reserve (DOR) after receiving an Anti-Müllerian Hormone (AMH) test result. Completing this practice will equip you with the ability to move beyond simple cutoffs and towards a more nuanced, probabilistic approach to clinical diagnosis and counseling.", "problem": "A 38-year-old nulligravid woman and her partner present for evaluation of infertility. The clinician is assessing the probability of Diminished Ovarian Reserve (DOR) and orders an Anti-Müllerian Hormone (AMH) test. At the chosen clinical cutoff, the test characteristics in this practice population are sensitivity $Se = 0.82$ and specificity $Sp = 0.78$. To quantify the pretest probability of DOR based on age, the clinic uses a logistic model grounded in prior epidemiologic data for infertile patients: the age-specific log-odds of DOR relative to age $35$ is given by $\\text{logit}(p_{\\text{pre}}) = \\alpha + \\beta (a - 35)$ with $\\alpha = \\ln\\!\\big(\\frac{0.25}{0.75}\\big)$ and $\\beta = 0.12$ (per year), where $a$ is age in years. The patient’s AMH test result is positive at the chosen cutoff (indicative of DOR at that threshold).\n\nUsing Bayes’ theorem from first principles, compute the posterior probability $p_{\\text{post}} = P(\\text{DOR} \\mid \\text{AMH positive})$ for this patient. Express your final answer as a decimal number with no units, and round your answer to four significant figures.", "solution": "The problem statement will first be validated for scientific soundness, completeness, and objectivity.\n\n**Problem Validation**\n\n**Step 1: Extract Givens**\nThe following data and definitions are provided in the problem statement:\n- Patient's age: $a = 38$ years\n- Condition being assessed: Diminished Ovarian Reserve (DOR)\n- Test used: Anti-Müllerian Hormone (AMH)\n- Test is positive.\n- Test sensitivity at the chosen cutoff: $Se = 0.82$\n- Test specificity at the chosen cutoff: $Sp = 0.78$\n- A logistic model for the age-specific pretest probability of DOR, $p_{\\text{pre}}$:\n$$ \\text{logit}(p_{\\text{pre}}) = \\alpha + \\beta (a - 35) $$\n- Model parameter $\\alpha = \\ln\\big(\\frac{0.25}{0.75}\\big)$\n- Model parameter $\\beta = 0.12$ per year\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem is firmly rooted in established principles of biostatistics, epidemiology, and reproductive endocrinology. The use of Anti-Müllerian Hormone (AMH) as a biomarker for ovarian reserve, the concepts of sensitivity and specificity for diagnostic tests, the application of logistic regression to model disease probability as a function of a risk factor (age), and the use of Bayes' theorem to update probability based on new evidence are all standard, valid scientific methods. The parameter values are plausible for a clinical context.\n- **Well-Posed:** The problem is well-posed. It provides all necessary information to compute a unique solution. The patient's age allows for the calculation of a pretest probability using the given model. The test characteristics (sensitivity and specificity) and the test outcome (positive) are provided, which are the required inputs for Bayes' theorem. The objective—to compute the posterior probability—is clearly stated.\n- **Objective:** The problem is stated in precise, objective, and quantitative terms. It is free of ambiguity, subjective claims, or opinion-based statements.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically sound, self-contained, and well-posed. It is therefore deemed **valid**. The solution will now be derived.\n\n**Solution Derivation**\n\nThe objective is to compute the posterior probability of the patient having Diminished Ovarian Reserve (DOR) given a positive Anti-Müllerian Hormone (AMH) test result. Let $D$ be the event that the patient has DOR, and let $T$ be the event that the AMH test is positive. We are asked to compute $p_{\\text{post}} = P(D \\mid T)$. This will be accomplished in two main steps: first, calculating the pretest probability $P(D)$ using the provided logistic model, and second, applying Bayes' theorem to find the posterior probability $P(D \\mid T)$.\n\n**Step 1: Calculation of Pretest Probability**\n\nThe pretest probability of DOR, $p_{\\text{pre}} = P(D)$, for this patient is determined by the logistic regression model based on her age, $a = 38$. The model for the log-odds (logit) of DOR is:\n$$ \\text{logit}(p_{\\text{pre}}) = \\alpha + \\beta (a - 35) $$\nThe logit function is defined as $\\text{logit}(p) = \\ln\\left(\\frac{p}{1-p}\\right)$. The given parameters are $\\alpha = \\ln\\left(\\frac{0.25}{0.75}\\right) = \\ln\\left(\\frac{1}{3}\\right) = -\\ln(3)$ and $\\beta = 0.12$.\n\nSubstituting the patient's age $a=38$ and the model parameters into the equation:\n$$ \\text{logit}(p_{\\text{pre}}) = -\\ln(3) + 0.12 (38 - 35) $$\n$$ \\text{logit}(p_{\\text{pre}}) = -\\ln(3) + 0.12(3) $$\n$$ \\text{logit}(p_{\\text{pre}}) = -\\ln(3) + 0.36 $$\n\nTo find $p_{\\text{pre}}$, we must apply the inverse logit (or sigmoid) function, $p = \\frac{\\exp(\\text{logit}(p))}{1+\\exp(\\text{logit}(p))}$.\n$$ p_{\\text{pre}} = \\frac{\\exp(-\\ln(3) + 0.36)}{1 + \\exp(-\\ln(3) + 0.36)} $$\nUsing the property $\\exp(x+y) = \\exp(x)\\exp(y)$ and $\\exp(-\\ln(z)) = 1/z$:\n$$ \\exp(-\\ln(3) + 0.36) = \\exp(-\\ln(3)) \\cdot \\exp(0.36) = \\frac{1}{3}\\exp(0.36) $$\nSubstituting this back into the expression for $p_{\\text{pre}}$:\n$$ p_{\\text{pre}} = \\frac{\\frac{1}{3}\\exp(0.36)}{1 + \\frac{1}{3}\\exp(0.36)} = \\frac{\\exp(0.36)}{3 + \\exp(0.36)} $$\nNow, we compute the numerical value for $p_{\\text{pre}}$:\n$$ p_{\\text{pre}} \\approx \\frac{1.433329}{3 + 1.433329} = \\frac{1.433329}{4.433329} \\approx 0.323296 $$\n\n**Step 2: Application of Bayes' Theorem**\n\nBayes' theorem states that the posterior probability $P(D \\mid T)$ is given by:\n$$ P(D \\mid T) = \\frac{P(T \\mid D) P(D)}{P(T)} $$\nThe denominator, $P(T)$, is the total probability of a positive test, which can be expanded using the law of total probability:\n$$ P(T) = P(T \\mid D)P(D) + P(T \\mid \\neg D)P(\\neg D) $$\nwhere $\\neg D$ is the event that the patient does not have DOR.\n\nLet's identify each term from the problem statement:\n- $P(D) = p_{\\text{pre}}$ is the pretest probability we just calculated.\n- $P(\\neg D) = 1 - P(D) = 1 - p_{\\text{pre}}$.\n- $P(T \\mid D)$ is the probability of a positive test given the disease is present, which is the sensitivity, $Se = 0.82$.\n- $P(T \\mid \\neg D)$ is the probability of a positive test given the disease is absent. This is the false positive rate, which is equal to $1 - \\text{specificity}$. The specificity is $Sp = P(\\neg T \\mid \\neg D) = 0.78$. Therefore, $P(T \\mid \\neg D) = 1 - Sp = 1 - 0.78 = 0.22$.\n\nSubstituting these into the formula for Bayes' theorem:\n$$ p_{\\text{post}} = P(D \\mid T) = \\frac{Se \\cdot p_{\\text{pre}}}{Se \\cdot p_{\\text{pre}} + (1 - Sp) \\cdot (1 - p_{\\text{pre}})} $$\n\nNow, we substitute the numerical values:\n- $p_{\\text{pre}} \\approx 0.323296$\n- $1 - p_{\\text{pre}} \\approx 1 - 0.323296 = 0.676704$\n- $Se = 0.82$\n- $1 - Sp = 0.22$\n\n$$ p_{\\text{post}} = \\frac{0.82 \\times 0.323296}{(0.82 \\times 0.323296) + (0.22 \\times 0.676704)} $$\n$$ p_{\\text{post}} = \\frac{0.26510272}{0.26510272 + 0.14887485} $$\n$$ p_{\\text{post}} = \\frac{0.26510272}{0.41397757} \\approx 0.640378 $$\n\nThe problem requires the final answer to be rounded to four significant figures.\n$$ p_{\\text{post}} \\approx 0.6404 $$\nThus, the posterior probability that this patient has Diminished Ovarian Reserve, given her age and positive AMH test result, is approximately $0.6404$.", "answer": "$$\n\\boxed{0.6404}\n$$", "id": "4435621"}]}